Mucosal administration of antigen is known to have tolerogenic potential; h
owever, it may also prime systemic cytotoxic T lymphocytes (CTL) and even e
xacerbate autoimmune disease. Here, Leonard C. Harrison and colleagues use
the nonobese diabetic (NOD) mouse model of diabetes to develop strategies t
o minimize immunity and maximize tolerance, that have broad implications fo
r other diseases.